-
Je něco špatně v tomto záznamu ?
Efficacy and analgesic use during the therapy of iatrogenic pneumothorax using Pleuralvent™ and Chest Tube (ASPIRATE): A randomised controlled trial protocol
M. Sova, M. Poruba, S. Genzor, P. Jakubec, J. Zatloukal, V. Kolek, K. Urbanek, M. Vasakova, L. Stehlik, P. Zackova, A. G. Asswad
Jazyk angličtina Země Česko
Typ dokumentu protokol klinické studie, časopisecké články
NLK
Directory of Open Access Journals
od 2001
Free Medical Journals
od 1998
Medline Complete (EBSCOhost)
od 2007-06-01
ROAD: Directory of Open Access Scholarly Resources
od 2001
PubMed
32153301
DOI
10.5507/bp.2020.008
Knihovny.cz E-zdroje
- MeSH
- analgetika terapeutické užití MeSH
- bolesti na hrudi farmakoterapie etiologie MeSH
- hrudní trubice * MeSH
- iatrogenní nemoci * MeSH
- lidé MeSH
- pneumotorax terapie MeSH
- randomizované kontrolované studie jako téma MeSH
- thorakocentéza škodlivé účinky přístrojové vybavení metody MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- protokol klinické studie MeSH
BACKGROUND: Iatrogenic pneumothorax is a common complication of various diagnostic and therapeutic procedures such as transbronchial lung biopsies. The classical mode of treatment is chest tube insertion. Pneumothorax devices are now available on the market but there is a dearth of data on their efficacy to treat iatrogenic pneumothorax. It is important to provide such data as the pathophysiology of iatrogenic pneumothorax is different in comparison with spontaneous pneumothorax for which some data is available. METHODS: This is a randomized, non-blinded, actively controlled trial of effectivity of iatrogenic pneumothorax treatment using the Pleuralvent™ device and chest tube insertion (16F). The secondary aim is to compare the overall pain level and the need for analgesic treatment in both treatment arms. We are planning to enrol 126 patients (63 in each treatment arm). DISCUSSION: Preliminary results showed similar effectivity of the Pleuralvent™ system compared to large bore chest tube insertion. This randomized clinical trial should confirm these results and prove that the Pleuralvent™ system is an effective way of treatment of patients with iatrogenic pneumothorax. If Pleuralvent™ proves to have the same level of efficacy, it may become the standard of care of patients with iatrogenic pneumothorax. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03700554.
Citace poskytuje Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21014140
- 003
- CZ-PrNML
- 005
- 20210528092857.0
- 007
- ta
- 008
- 210504s2020 xr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2020.008 $2 doi
- 035 __
- $a (PubMed)32153301
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Sova, Milan $7 xx0140833 $u Department of Respiratory Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic
- 245 10
- $a Efficacy and analgesic use during the therapy of iatrogenic pneumothorax using Pleuralvent™ and Chest Tube (ASPIRATE): A randomised controlled trial protocol / $c M. Sova, M. Poruba, S. Genzor, P. Jakubec, J. Zatloukal, V. Kolek, K. Urbanek, M. Vasakova, L. Stehlik, P. Zackova, A. G. Asswad
- 504 __
- $a Literatura
- 520 9_
- $a BACKGROUND: Iatrogenic pneumothorax is a common complication of various diagnostic and therapeutic procedures such as transbronchial lung biopsies. The classical mode of treatment is chest tube insertion. Pneumothorax devices are now available on the market but there is a dearth of data on their efficacy to treat iatrogenic pneumothorax. It is important to provide such data as the pathophysiology of iatrogenic pneumothorax is different in comparison with spontaneous pneumothorax for which some data is available. METHODS: This is a randomized, non-blinded, actively controlled trial of effectivity of iatrogenic pneumothorax treatment using the Pleuralvent™ device and chest tube insertion (16F). The secondary aim is to compare the overall pain level and the need for analgesic treatment in both treatment arms. We are planning to enrol 126 patients (63 in each treatment arm). DISCUSSION: Preliminary results showed similar effectivity of the Pleuralvent™ system compared to large bore chest tube insertion. This randomized clinical trial should confirm these results and prove that the Pleuralvent™ system is an effective way of treatment of patients with iatrogenic pneumothorax. If Pleuralvent™ proves to have the same level of efficacy, it may become the standard of care of patients with iatrogenic pneumothorax. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03700554.
- 650 _2
- $a analgetika $x terapeutické užití $7 D000700
- 650 _2
- $a bolesti na hrudi $x farmakoterapie $x etiologie $7 D002637
- 650 12
- $a hrudní trubice $7 D015505
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a iatrogenní nemoci $7 D007049
- 650 _2
- $a pneumotorax $x terapie $7 D011030
- 650 _2
- $a randomizované kontrolované studie jako téma $7 D016032
- 650 _2
- $a thorakocentéza $x škodlivé účinky $x přístrojové vybavení $x metody $7 D000069258
- 655 _2
- $a protokol klinické studie $7 D000078325
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Poruba, Martin $7 xx0230224 $u Department of Pharmacology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic
- 700 1_
- $a Genzor, Samuel $7 xx0219019 $u Department of Respiratory Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic
- 700 1_
- $a Jakubec, Petr, $d 1971- $7 mzk2007381840 $u Department of Respiratory Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic
- 700 1_
- $a Zatloukal, Jaromír $7 xx0113000 $u Department of Respiratory Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic
- 700 1_
- $a Kolek, Vítězslav, $d 1953-2020 $7 jn20000401390 $u Department of Respiratory Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic
- 700 1_
- $a Urbánek, Karel, $d 1969- $7 xx0078289 $u Department of Pharmacology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic
- 700 1_
- $a Koziar Vašáková, Martina, $d 1964- $7 xx0104496 $u Department of Respiratory Medicine, 1st Faculty of Medicine Charles University in Prague, Thomayer Hospital Prague, Czech Republic
- 700 1_
- $a Stehlík, Luděk, $d 1980- $7 xx0141866 $u Department of Respiratory Medicine, 1st Faculty of Medicine Charles University in Prague, Thomayer Hospital Prague, Czech Republic
- 700 1_
- $a Žáčková, Pavla, $d 1957- $7 xx0069556 $u Department of Respiratory Medicine, 1st Faculty of Medicine Charles University in Prague, Thomayer Hospital Prague, Czech Republic
- 700 1_
- $a Asswad, Amjad Ghazal $u Emergency Department, West Middlesex University Hospital, London, United Kingdom of Great Britain and Northern Ireland
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia $x 1213-8118 $g Roč. 164, č. 2 (2020), s. 213-215
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32153301 $y Pubmed
- 910 __
- $a ABA008 $b A 1502 $c 958 $y p $z 0
- 990 __
- $a 20210504 $b ABA008
- 991 __
- $a 20210524144643 $b ABA008
- 999 __
- $a ok $b bmc $g 1657553 $s 1134528
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 164 $c 2 $d 213-215 $e 20200309 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- LZP __
- $b NLK118 $a Pubmed-20210504
